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Abstract 
Nano-carbons, including fullerenes, carbon nanoparticles, carbon nanotubes, graphene, and 
nano-diamonds, are an important class of nanostructures attracting tremendous interests in 
the past two decades. In this special issue, seven review articles and research reports are 
collected,  to  summarize  and  present  the  latest  progress  in  the  exploration  of  various 
nano-carbons for theranostic applications. 
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The rapid development in nanoscience and nan-
otechnology has brought great opportunities to bio-
medical  research  in  various  directions.  Among  nu-
merous types of nanomaterials developed in the past 
many years, carbon nanomaterials, or nano-carbons, 
have attracted particular interests in a large variety of 
fields  including  biomedicine  [1-5],  owing  to  their 
highly-enriched  distinctive  physical  and  chemical 
properties.  
Based on their bonding structures, nano-carbons 
may be classified into sp2-carbon nanomaterials and 
sp3-carbon nanomaterials (Fig. 1). Typical sp2-carbon 
nanomaterials  include  zero-dimensional  (0D)  fuller-
ene, one-dimensional (1D) carbon nanotubes (CNTs), 
and  two-dimensional  (2D)  graphene,  all  with 
well-defined structures. Remarkably, the discoveries 
of fullerene and graphene have been awarded with 
Nobel prizes in 1996 (Chemistry) and 2010 (Physics), 
respectively.  Carbon  nanoparticles  or  carbon  dots 
(CDots), are nano-clusters of amorphous carbon (or 
composed by small crystalline structures) with sizes 
smaller than 10 nm, and may also be deemed as a type 
of  0D  sp2-carbon  nanomaterials.  Sp3-carbon  nano-
materials,  on  the  other  hand,  usually  are 
nano-diamonds  (NDs)  with  crystal  sizes  in  the 
nano-range. 
 
Figure 1. Different types of nano-carbons explored for theranostic applications. 
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There are many motivations and reasons of us-
ing  nano-carbons  for  biomedical  applications  (e.g. 
theranostics).  Many  nano-carbons,  including  CNTs, 
graphene  derivatives,  Cdots,  and  NDs,  show  inter-
esting  inherent  optical  properties  such  as  fluores-
cence, making them useful contrast agents in optical 
imaging  and  sensing  [6-11].  The  excellent  electrical 
properties of CNTs and graphene, on the other hand, 
allow them to be extensively used in a wide range of 
biosensing platforms [12-14]. Sp2-carbon nanomateri-
als  especially  single-walled  carbon  nanotubes 
(SWNTs)  and  graphene  with  all  carbon  atoms  ex-
posed on their surfaces, exhibit ultra-high surface area 
available for  efficient drug loading and bioconjuga-
tion[1, 10, 15, 16]. For fullerene and CNTs with hollow 
structures, the inside space may be utilized to load 
other  functional  species  for  theranostic  purpos-
es[17-20]. CNTs and graphene derivatives with strong 
optical absorbance in the near-infrared region are also 
useful  for  photothermal  ablation  of  cancer[21-25]. 
Moreover, compared with many other inorganic na-
nomaterials such as quantum dots (QDs) which usu-
ally  contain  heavy  metals,  nano-carbons  composed 
simply by carbon are relatively safe at least in term of 
elementary composition.  
In  this  special  issue,  we  invite  colleagues 
worldwide who have been exploring biomedical ap-
plications of nano-carbons for years, to discuss and 
report  cutting-edge  research  in  the  use  of 
nano-carbons as theranostics:  
In the first article, Chen et al. [26] offer a com-
prehensive review to summarize the applications of 
functionalized fullerenes in tumor theranostics. Func-
tionalized fullerenes have not only shown potential in 
several different cancer therapeutic approaches such 
as  photodynamic  therapy,  photothermal  treatment, 
radiotherapy and chemotherapy, but also been used 
as novel contrast agents in magnetic resonance (MR) 
imaging. The biodistribution, metabolism and toxicity 
of those functionalized fullerenes are also reviewed in 
this article. 
In  the  following  section,  three  articles  are  col-
lected to highlight the promise of using CNTs for po-
tential disease theranostics. Mandal et al. [27] report a 
label-free  real-time  electrical  detection  of  whole  vi-
ruses using CNT think film field effect devices, and 
achieve an ultra-high sensitivity which is 5 orders of 
magnitude  higher  than  traditional  electrical  imped-
ance sensors without CNTs. In the next article, Xu and 
co-workers [28] present an interesting study to inves-
tigate the influence of oxidized multi-walled carbon 
nanotubes (o-MWNTs) on marcophages. It is uncov-
ered that subcutaneous injection of o-MWNTs would 
lead to macrophage reduction and decreased vessel 
density  in  the  tumor  by  competing  with  the  tumor 
mass for recruitment of macrophages from circulating 
monocytes, resulting in the inhibition of tumor pro-
gression and metastasis. This finding presents a novel 
approach of using CNTs in cancer immunotherapy. 
Besides these two research articles, a review article is 
contributed by Yang et al. [29] to discuss the phar-
macokinetics,  metabolism  and  toxicity  of  CNTs  in 
details.  Surveying  others  reports  and  the  authors’ 
own  findings,  it  is  summarized  that  the  surface 
chemistry of CNTs is crucial in regulating the in vivo 
behaviors  of  CNTs.  Compared  with 
non-functionalized CNTs,  well functionalized CNTs 
(e.g.  by  PEGylation)  by  both  covalent  and 
non-covalent methods are much less toxic in vitro and 
in vivo, and may be preferred for applications in bi-
omedicine. However, the authors also point out that 
future studies are still needed to systematically eval-
uate long-term toxicity of CNT-exposure. Establishing 
fast and reliable analytical tools to study in vivo be-
haviors  of  CNTs  as  well  as  other  newly  developed 
nanomaterials is also of great importance. 
Graphene  has  been  a  shining  star  in  materials 
science  since  2004.  Its  applications  in  biomedicine 
have also aroused widespread interest. In the article 
by Zhang and co-workers [30], the authors summarize 
the  latest  progress  of  applying  graphene  and  gra-
phene  derivatives  in  various  directions  of  biomedi-
cine including drug and gene delivery, cancer thera-
pies, biomedical imaging, biosensing, as well as tissue 
engineering  scaffolds.  The  opportunities  and  chal-
lenges in this rapidly developing field are also dis-
cussed. 
Cdots  are  surface-functionalized  small  carbon 
nanoparticles,  which  with  certain  modification, 
would emit bright fluorescence useful in biomedical 
imaging. In the  article by  Sun and co-workers [31], 
highly fluorescent Cdots without and with ZnS dop-
ing are prepared and evaluated for optical imaging in 
mice. Significantly, competitive performance of Cdots 
in vivo to that of well-established CdSe/ZnS QDs is 
observed, suggesting that Cdots may be a new class of 
non-heavy-metal containing optical probes promising 
in bioimaging. 
In  additions  to  sp2-carbon  nanomaterials,  NDs 
with sp3-bonded structure have also been extensively 
explored in nanomedicine. The last article of this issue 
is contributed by Zhu et al. [32] to review the in vitro 
and in vivo toxicity of NDs as well as their applica-
tions in drug delivery systems. With rather different 
properties  and  behaviors  from  sp2  carbon  nano-
materials  such  as  CNTs  and  graphene,  NDs  and 
ND-clusters appear to be relatively safe in biological 




carriers for fluorescent imaging guided delivery. 
In  summary,  the  development  of  novel 
theranostic  approaches  based  on  nano-carbons  has 
been and would remain to be an area attracting great 
attention  in  the  field  of  nanomedicine.  This  special 
issue containing 4 review articles and 3  original re-
search  reports  covers  all  widely  explored 
nano-carbons in biomedicine. At this point, we would 
like to thank all the authors for their excellent contri-
bution in this project, and hope that our issue would 
be informative and beneficial for researchers working 
in or interested in this area! 
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